Stockreport

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet [Yahoo! Finance]

CARGO Therapeutics, Inc.  (CRGX) 
PDF autoleucel (firi-cel) , in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) Notable patient subset analyses show durability of Complete Response [Read more]